Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $101.08 USD
Change Today +0.62 / 0.62%
Volume 6.6M
JNJ On Other Exchanges
Symbol
Exchange
Mexico
Sao Paulo
Bogota
As of 8:04 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Seth H. Z. Fischer

Former Group Chairman, Johnson & Johnson
AgeTotal Calculated CompensationThis person is connected to 34 board members in 3 different organizations across 5 different industries.

See Board Relationships
57$8,323,606

Background*

Mr. Seth H. Z. Fischer has been the Chief Executive Officer of VIVUS Inc. since September 3, 2013 and as its Chief Commercial Officer since January 16, 2014. Mr. Fischer is advisor to MedHab, LLC. Mr. Fischer served as President of Ortho-McNeil Pharmaceuticals from 2000 to 2004. Mr. Fischer operating responsibilities encompassed the commercialization of products in multiple therapeutic categories including the oral and IV anti-infectives Levaquin® and Floxin®, cardiovasculars, ...

Read Full Background

Corporate Headquarters*

One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933

United States

Phone: 732-524-0400
Fax: --

Board Members Memberships*

Former Group Chairman and Worldwide Franchise Chairman
2013-Present
Chief Executive Officer, Chief Commercial Officer and Director
2013-Present
Independent Director
2013-Present
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$212,083
Total Annual Compensation$212,083

Stock Options*

All Other Compensation$15,965
Exercisable Options83,333
Unexercisable Options916,667
Total Number of Options1,000,000

Total Compensation*

Total Annual Cash Compensation$332,048
Total Short Term Compensation$212,083
Other Long Term Compensation$15,965
Total Calculated Compensation$8,323,606
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $101.08 USD +0.62

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Zubair Ahmed Managing Director, Senior Vice President of Indian Sub Continent, Executive Director and Member of Whistle Blower Committee
GlaxoSmithKline Consumer Healthcare Limited
97.4M
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
$640.6K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.